Roseman L

Department of Psychology, University of Exeter, UK.

65 papers · 28 preprints · ORCID

ArticlePsilocybin

Defining 'psychedelic'.

Ostrand AE, Nour MM, Timmermann C +7

Europe PMC2026
PreprintAyahuasca

Ayahuasca rituals among ultra-Orthodox (Haredi) Jews: context, phenomenology, changes, and negotiations

David J, Berkovich-Ohana A, Dor-Ziderman Y +3

Europe PMC2026
ArticlePsilocybin

Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits.

Pasquini L, Vohryzek J, Escrichs A +12

Europe PMC2026
PreprintAyahuasca

Ayahuasca rituals among ultra-Orthodox (Haredi) Jews: context, phenomenology, changes, and negotiations

David J, Berkovich-Ohana A, Dor-Ziderman Y +3

Europe PMC2026
PreprintAyahuasca

Koshering Psychedelics: Ayahuasca in the Ultra-Orthodox (Haredi) Jewish World

David J, Berkovich-Ohana A, Dor-Ziderman Y +3

Europe PMC2026
ArticlePsilocybin

Human brain changes after first psilocybin use.

Lyons T, Spriggs M, Kerkelä L +20

Europe PMC2026
ArticlePsilocybin

Effects of psychedelic use on authoritarian attitudes revisited.

Simonsson O, Lyons T, Marks J +5

Europe PMC2026
ArticlePsilocybin

An international mega-analysis of psychedelic drug effects on brain circuit function.

Girn M, Doss MK, Roseman L +24

Europe PMC2026
ArticlePsychedelics

How to set up a psychedelic study: Unique considerations for research involving human participants.

Glennon MJ, Bird CIV, Yadav P +18

Europe PMC2026
ArticlePsychedelics

Towards social curative psychedelic treatment.

Newson M, Roseman L, Haslam SA

Europe PMC2026
PreprintPsychedelics

Dorsal-ventral precuneus gradients organise large-scale networks and track consciousness level

Lu D, Ram A, Carhart-Harris R +5

Europe PMC2026
ArticlePsychedelics

Learning from boundlessness: epistemic shifts towards a holistic worldview following psychedelic experiences.

Argyri EK, Fraser F, Schilling S +4

Europe PMC2026
PreprintPsilocybin

Defining ‘psychedelic’

Ostrand A, Nour M, Timmermann C +7

Europe PMC2025
ArticlePsilocybin

A Virtual Clinical Trial of Psychedelics to Treat Patients With Disorders of Consciousness.

Alnagger NLN, Cardone P, Martial C +15

Europe PMC2026
ArticleMDMA

Dissociable effects of LSD and MDMA on striato-cortical connectivity in healthy subjects.

Ertl N, Ashraf I, Azizi L +5

Europe PMC2026
ArticlePsilocybin

Improved mental health outcomes and normalised spontaneous EEG activity in veterans reporting a history of traumatic brain injuries following participation in a psilocybin retreat.

Blest-Hopley G, Pasculli G, Ruffell SGD +7

Europe PMC2025
PreprintPsilocybin

Accurate and Interpretable Prediction of Antidepressant Treatment Response from Receptor-informed Neuroimaging

Tolle HM, Luppi AI, Lawn T +4

Europe PMC2025
ArticlePsilocybin

Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings.

Calnan M, Blest-Hopley G, Busch C +6

Europe PMC2025
ArticlePsilocybin

Correction: Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.

Harding R, Singer N, Wall MB +5

Europe PMC2025
ArticlePsilocybin

Enhanced meaning in life following psychedelic use: converging evidence from controlled and naturalistic studies.

Roseby W, Kettner H, Roseman L +7

Europe PMC2025
ArticlePsychedelics

An international Delphi consensus for reporting of setting in psychedelic clinical trials.

Pronovost-Morgan C, Greenway KT, Roseman L

Europe PMC2025
ArticlePsilocybin

Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression.

Wall MB, Demetriou L, Giribaldi B +5

Europe PMC2025
ArticlePsilocybin

Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.

Harding R, Singer N, Wall MB +5

Europe PMC2025
ArticleDMT

Network control energy reductions under DMT relate to serotonin receptors, signal diversity, and subjective experience.

Singleton SP, Timmermann C, Luppi AI +4

Europe PMC2025
ArticleDMT

Dynamic medial parietal and hippocampal deactivations under DMT relate to sympathetic output and altered sense of time, space, and the self.

Pasquini L, Simon AJ, Gallen CL +5

Europe PMC2025
ArticleLSD

The Role of the Dorsolateral Prefrontal Cortex in Ego Dissolution and Emotional Arousal During the Psychedelic State.

Coleman CR, Shinozuka K, Tromm R +7

Europe PMC2025
PreprintPsychedelics

Learning from Boundlessness: Psychedelic induced awe and epistemic shifts towards a holistic worldview

Argyri EK, Fraser F, Schilling S +4

Europe PMC2025
PreprintLSD

LSD reconfigures the frequency-specific network landscape of the human brain

Shinozuka K, Rosso M, Coleman CR +8

Europe PMC2025
PreprintMDMA

Dissociable effects of LSD and MDMA on striato-cortical connectivity in healthy subjects

Ertl N, Ashraf I, Azizi L +5

Europe PMC2025
ArticleLSD

LSD flattens the hierarchy of directed information flow in fast whole-brain dynamics.

Shinozuka K, Tewarie PKB, Luppi A +7

Europe PMC2025
ArticleMDMA

A reflection on paradigmatic tensions within the FDA advisory committee for MDMA-assisted therapy.

Roseman L

Europe PMC2025
PreprintPsilocybin

Brain dynamics of classical psychedelics show paradoxical hierarchical flattening with increased complexity

Vohryzek J, Garcia Guzman E, Kringelbach ML +8

Europe PMC2024
PreprintPsychedelics

Diminished functional gradient of the precuneus during altered states of consciousness

Lyu D, Adapa R, Carhart-Harris RL +5

Europe PMC2024
PreprintLSD

The Role of the Dorsolateral Prefrontal Cortex in Ego Dissolution and Emotional Arousal During the Psychedelic State

Coleman CR, Shinozuka K, Tromm R +7

Europe PMC2024
PreprintPsilocybin

Long-term effects of psilocybin on dynamic and effectivity connectivity of fronto-striatal-thalamic circuits

Pasquini L, Vohryzek J, Escrichs A +12

Europe PMC2024
PreprintPsilocybin

Human brain changes after first psilocybin use

Lyons T, Spriggs M, Kerkelä L +20

Europe PMC2024
ArticlePsilocybin

Co-administration of midazolam and psilocybin: differential effects on subjective quality versus memory of the psychedelic experience.

Nicholas CR, Banks MI, Lennertz RC +9

Europe PMC2024
PreprintPsilocybin

A virtual clinical trial of psychedelics to treat patients with disorders of consciousness

Alnagger NL, Cardone P, Martial C +15

Europe PMC2024
ArticlePsychedelics

Interrupting the Psychedelic Experience Through Contextual Manipulation to Study Experience Efficacy.

Roseman L, Erritzoe D, Nutt D +2

Europe PMC2024
PreprintPsilocybin

Co-administration of midazolam and psilocybin: Differential effects on subjective quality versus memory of the psychedelic experience

Nicholas CR, Banks MI, Lennertz RL +9

Europe PMC2024
ArticlePsychedelics

Effects of Psychedelics in Older Adults: A Prospective Cohort Study.

Kettner H, Roseman L, Gazzaley A +2

Europe PMC2024
PreprintLSD

LSD flattens the hierarchy of directed information flow in fast whole-brain dynamics

Shinozuka K, Tewarie PK, Luppi A +7

Europe PMC2024
ArticleDMT

The flattening of spacetime hierarchy of the <i>N,N</i>-dimethyltryptamine brain state is characterized by harmonic decomposition of spacetime (HADES) framework.

Vohryzek J, Cabral J, Timmermann C +6

Europe PMC2024
PreprintDMT

Dynamic medial parietal and hippocampal deactivations under DMT relate to sympathetic output and altered sense of time, space, and the self

Pasquini L, Simon AJ, Gallen CL +5

Europe PMC2024
ArticlePsilocybin

Brain dynamics predictive of response to psilocybin for treatment-resistant depression.

Vohryzek J, Cabral J, Lord LD +6

Europe PMC2024
ArticlePsilocybin

Psychedelics and sexual functioning: a mixed-methods study.

Barba T, Kettner H, Radu C +6

Europe PMC2024
ArticleLSD

Effects of External Stimulation on Psychedelic State Neurodynamics.

Mediano PAM, Rosas FE, Timmermann C +10

Europe PMC2024
ArticlePsilocybin

Is Poorly Assisted Psilocybin Treatment an Increasing Risk?

Schenberg EE, King F 4th, da Fonseca JE +1

Europe PMC2024
ArticleLSD

LSD-induced changes in the functional connectivity of distinct thalamic nuclei.

Delli Pizzi S, Chiacchiaretta P, Sestieri C +10

Europe PMC2023
PreprintDMT

Harmonic decomposition of spacetime (HADES) framework characterises the spacetime hierarchy of the DMT brain state

Vohryzek J, Cabral J, Timmermann C +6

Europe PMC2023
ArticlePsilocybin

In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape.

Luppi AI, Hansen JY, Adapa R +23

Europe PMC2023
ArticlePsychedelics

Psychedelic therapy in the treatment of addiction: the past, present and future.

Zafar R, Siegel M, Harding R +7

Europe PMC2023
PreprintDMT

Time-resolved network control analysis links reduced control energy under DMT with the serotonin 2a receptor, signal diversity, and subjective experience

Singleton SP, Timmermann C, Luppi AI +4

Europe PMC2023
ArticlePsilocybin

Increased low-frequency brain responses to music after psilocybin therapy for depression.

Wall MB, Lam C, Ertl N +4

Europe PMC2023
ArticlePsilocybin

Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique.

Mosurinjohn S, Roseman L, Girn M

Europe PMC2023
ArticleLSD

Spatial Correspondence of LSD-Induced Variations on Brain Functioning at Rest With Serotonin Receptor Expression.

Delli Pizzi S, Chiacchiaretta P, Sestieri C +8

Europe PMC2023
ArticleDMT

Human brain effects of DMT assessed via EEG-fMRI.

Timmermann C, Roseman L, Haridas S +12

Europe PMC2023
ArticleKetamine

Distributed harmonic patterns of structure-function dependence orchestrate human consciousness.

Luppi AI, Vohryzek J, Kringelbach ML +16

Europe PMC2023
ArticlePsilocybin

Canalization and plasticity in psychopathology.

Carhart-Harris RL, Chandaria S, Erritzoe DE +11

Europe PMC2023
ArticlePsilocybin

Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression.

Shukuroglou M, Roseman L, Wall M +3

Europe PMC2023
ArticlePsilocybin

Body mass index (BMI) does not predict responses to psilocybin.

Spriggs MJ, Giribaldi B, Lyons T +9

Europe PMC2023
ArticlePsilocybin

Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain's control energy landscape.

Singleton SP, Luppi AI, Carhart-Harris RL +7

Europe PMC2022
ArticlePsilocybin

Effects of classic psychedelic drugs on turbulent signatures in brain dynamics.

Cruzat J, Perl YS, Escrichs A +10

Europe PMC2022
PreprintPsilocybin

Brain dynamics predictive of response to psilocybin for treatment-resistant depression

Vohryzek J, Cabral J, Lord L +6

Europe PMC2022
ArticlePsilocybin

Effects of psilocybin versus escitalopram on rumination and thought suppression in depression.

Barba T, Buehler S, Kettner H +6

Europe PMC2022
ArticlePsilocybin

The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.

Watts R, Kettner H, Geerts D +9

Europe PMC2022
ArticlePsilocybin

Editorial: Psychedelic sociality: Pharmacological and extrapharmacological perspectives.

Roseman L, Preller KH, Fotiou E +1

Europe PMC2022
PreprintPsilocybin

Mapping Pharmacologically-induced Functional Reorganisation onto the Brain’s Neurotransmitter Landscape

Luppi AI, Hansen JY, Adapa R +24

Europe PMC2022
PreprintPsilocybin

Brain dynamics predictive of response to psilocybin for treatment-resistant depression

Vohryzek J, Cabral J, Lord L +6

Europe PMC2022
ArticlePsilocybin

Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex.

Girn M, Roseman L, Bernhardt B +3

Europe PMC2022
PreprintPsilocybin

Increased low-frequency brain responses to music after psilocybin therapy for depression

Wall MB, Lam C, Ertl N +4

Europe PMC2022
ArticlePsilocybin

The Psychedelic Renaissance in Clinical Research: A Bibliometric Analysis of Three Decades of Human Studies with Psychedelics.

Hadar A, David J, Shalit N +4

Europe PMC2023
ArticlePsychedelics

Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience.

Peill JM, Trinci KE, Kettner H +6

Europe PMC2022
ArticlePsychedelics

Psychedelics alter metaphysical beliefs.

Timmermann C, Kettner H, Letheby C +3

Europe PMC2021
ArticlePsychedelics

Self-Medication for Chronic Pain Using Classic Psychedelics: A Qualitative Investigation to Inform Future Research.

Bornemann J, Close JB, Spriggs MJ +2

Europe PMC2021
ArticleAyahuasca

On Revelations and Revolutions: Drinking Ayahuasca Among Palestinians Under Israeli Occupation.

Roseman L, Karkabi N

Europe PMC2021
ArticleAyahuasca

Relational Processes in Ayahuasca Groups of Palestinians and Israelis.

Roseman L, Ron Y, Saca A +5

Europe PMC2021
PreprintPsilocybin

LSD and psilocybin flatten the brain’s energy landscape: insights from receptor-informed network control theory

Singleton SP, Luppi AI, Carhart-Harris RL +7

Europe PMC2021
ArticlePsychedelics

Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness.

Kettner H, Rosas FE, Timmermann C +3

Europe PMC2021
ArticleLSD

Increased sensitivity to strong perturbations in a whole-brain model of LSD.

Jobst BM, Atasoy S, Ponce-Alvarez A +6

Europe PMC2021
ArticlePsychedelics

Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing.

Kaertner LS, Steinborn MB, Kettner H +7

Europe PMC2021
PreprintLSD

Increased sensitivity to strong perturbations in a whole-brain model of LSD

Jobst BM, Atasoy S, Ponce-Alvarez A +6

Europe PMC2021
ArticleLSD

LSD alters dynamic integration and segregation in the human brain.

Luppi AI, Carhart-Harris RL, Roseman L +3

Europe PMC2021
PreprintKetamine

Distributed harmonic patterns of structure-function dependence orchestrate human consciousness

Luppi AI, Vohryzek J, Kringelbach ML +16

Europe PMC2020
ArticlePsilocybin

Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains.

Varley TF, Carhart-Harris R, Roseman L +2

Europe PMC2020
PreprintPsilocybin

Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex

Girn M, Roseman L, Bernhardt B +3

Europe PMC2020
ArticleDMT

Neural correlates of the DMT experience assessed with multivariate EEG.

Timmermann C, Roseman L, Schartner M +13

Europe PMC2019
ArticlePsychedelics

Predicting Responses to Psychedelics: A Prospective Study.

Haijen ECHM, Kaelen M, Roseman L +8

Europe PMC2018
ArticlePsilocybin

Psychedelics, Meditation, and Self-Consciousness.

Millière R, Carhart-Harris RL, Roseman L +2

Europe PMC2018
ArticleDMT

DMT Models the Near-Death Experience.

Timmermann C, Roseman L, Williams L +6

Europe PMC2018
ArticlePsilocybin

Effects of psilocybin therapy on personality structure.

Erritzoe D, Roseman L, Nour MM +4

Europe PMC2018
ArticleLSD

LSD alters eyes-closed functional connectivity within the early visual cortex in a retinotopic fashion.

Roseman L, Sereno MI, Leech R +6

Europe PMC2016
ArticleLSD

Neural correlates of the LSD experience revealed by multimodal neuroimaging.

Carhart-Harris RL, Muthukumaraswamy S, Roseman L +23

Europe PMC2016